Nantahala Capital Management »

AgomAb Therapeutics NV shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 1.2M 10.71

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Peloton Interactive Cl A Com (PTON)
Herbalife Com Shs (HLF)
Hilton Grand Vacations (HGV)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Viatris Call Option (VTRS)
Edwards Lifesciences Put Option (EW)
Bioventus Com Cl A (BVS)
Establishment Labs Holdings Ord (ESTA)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Savara (SVRA)
Spdr Series Trust State Street Spd Put Option (XBI)
Xtant Med Hldgs Com New (XTNT)

View all positions for Nantahala Capital Management

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
Nantahala Capital Management
Standard Life Aberdeen
Samsara BioCapital
Perceptive Advisors
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management
Alyeska Investment Group

View all funds holding AgomAb Therapeutics NV